Brief: Tg Therapeutics Provides Business Update And Reports Fourth Quarter And Year-End 2022 Financial Results
Feb 28 (Reuters) - Tg Therapeutics Inc TGTX.O :
* TG THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS
FOURTH
QUARTER AND YEAR-END 2022 FINANCIAL RESULTS
* SEES CASH, INVESTMENTS AS OF DEC 31, 2022, WITH $45.0
MILLION
UNDER TERM LOAN, TO BE SUFFICIENT TO FUND PLANNED OPERATIONS
INTO MID-2024
* QTRLY BASIC AND DILUTED NET LOSS PER COMMON SHARE $0.39
* Q4 EARNINGS PER SHARE VIEW $-0.26 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX2pPFrL
Further company coverage: TGTX.O
Recent news on TG Therapeutics
See all newsTG Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tg Therapeutics Reports Second Quarter 2026 Financial Results And Raises Briumvi® Revenue Guidance
TG Therapeutics Q2 product revenue rises 70% on BRIUMVI sales
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj